DO WE NEED TO RECOGNIZE the existence of two classes of pharmacists; should we have dispensing technologists instead of dispensing pharmacists? How and when will pharmacy answer this problem? One of my favorite quotations is from Ecclesiastes (3: I ,5, RSV):
For everything there is a season ... a time to embrace, and a time to refrain from embracing; ... Jere E. Goyan, Ph.D., provided his answer to the problem 16 years ago, and it appears in this issue. His editorial on pharmaceutical education is an adaptation of an unpublished paper that he presented in 1972. The concepts and recommendations Goyan put forth were not embraced, perhaps because it was not the right season. After reflecting on how little has been done since Goyan identified and addressed the problem, it is obvious to me that more thought should be given to how students in pharmacy are being educated and trained. A sharper focus and more distinction in career tracks is needed if his advice is to be heeded.
I disagreed with Goyan's idea of two kinds of pharmacists in 1972 and I disagree even more strongly today. Donald E. Francke, D.Sc., identified five levels of pharmacy practice: (I) the generic (nonclinical) pharmacist (also categorized as pharmacy technologist);
(2) the generic (clinical) pharmacist; (3) the clinical pharmacy generalist; (4) the clinical pharmacy specialist; and (5) the clinical scientist. As Francke stated, the profession needs to recognize that "it does not require the training a pharmacist receives to carry out the functions now performed by a large number of pharmacists," This is one of Goyan's arguments for establishing a pattern for educating "drug delivery specialists" (Francke's generic pharmacists).
I believe Goyan looked at the problem as an educator and proposed solving it by establishing a new curriculum for certain pharmacy schools (he calls them Group I). The difficulty is that few pharmacists want to be thought of as second-rate or lower-class. Moreover, most pharmacy schools would not want to be graduating the lower-class pharmacist. Francke's label of pharmacy technologist for the generic nonclinical pharmacist was more appropriate. It follows the established educational patterns of other health professions (e.g., medical technology, nuclear medicine technology).
The problem with both of these concepts is the implementation. There are too many pharmacists in practice who are not in favor of either concept. Until there are sufficient numbers of clinical pharmacists in responsible positions supporting the formal education of pharmacy technologists, a drastic change in the basic structure of pharmacy will not occur. Pharmacyeducation has responded to the needs of clinical pharmacists in the last 16 years, but it has neglected the education for the person responsible for dispensing. Although changes have occurred, the controversy over the education for pharmacy technologists or drug-delivery specialists remains the same. While we await the right season, it is interesting to consider the evolving pattern of pharmaceutical education. 
